 
ITEM  INSTRUCTIONS  
C0270/R0010 – 
R0330  Future cash–flows used in the 
Best estimate, Health 
reinsurance (gross), Cash in– 
flows – Future premiums  Amount of undiscounted cash–flows expected for each year from year 1 to year 
30, aggregated for the interval of years 31 to 40, aggregated for the interval of 
years 41 to 50 and aggregated for all the years after year 50. 
The cash– flows are the ones stemming from future premiums and any additional 
cash flows that result from those premiums, regarding line of business, as defined 
in Annex I to Delegated Regulation (EU) 2015/35, Health reinsurance.  
C0280/R0010 – 
R0330  Future cash–flows used in the 
Best estimate, Health 
reinsurance (gross), Cash in– 
flows – Other cash in–flows  Amount of undiscounted cash–flows expected for each year from year 1 to year 
30, aggregated for the interval of years 31 to 40, aggregated for the interval of 
years 41 to 50 and aggregated for all the years after year 50. 
The cash– flows are the ones not included in Future premiums and not including 
investment returns, regarding line of business, as defined in Annex I to Delegated 
Regulation (EU) 2015/35, Health reinsurance.  
C0285/R0010 – 
R0330  Future cash–flows used in the 
Best estimate, Health 
reinsurance (gross), Cash flows 
– Total recoverable from 
reinsurance (after the adjust ­
ment)  Amount of Health SLT insurance obligations undiscounted cash–flows expected 
for each year from year 1 to year 30, aggregated for the interval of years 31 to 
40, aggregated for the interval of years 41 to 50 and aggregated for all the years 
after year 50. 
The future cash–flows undiscounted from amounts recoverables from reinsurance 
and SPVs/Finite Re, including ceded intra group reinsurance, including future 
reinsurance premiums. Amount shall be reported net of adjustment for 
counterparty default risk.  
C0290/R0010- 
R0330  Future cash–flows used in the 
Best estimate – Total 
recoverable from reinsurance 
(after the adjustment)  Amount of Life and Health SLT undiscounted cash–flows expected for each year 
from year 1 to year 30, aggregated for the interval of years 31 to 40, aggregated 
for the interval of years 41 to 50 and aggregated for all the years after year 50. 
The future cash–flows undiscounted from amounts recoverables from reinsurance 
and SPVs/Finite Re, including ceded intra group reinsurance, including future 
reinsurance premiums. Amount shall be reported net of adjustment for 
counterparty default risk.  
S.14.01 – Life obligations analysis  
General comments:  
This section relates to annual submission of information for individual entities.  
This template includes information about life insurance contracts only to direct business and also includes life obligation 
from non-life contracts such as annuities stemming from non–life contracts (which are also analysed in S.16.01). 
No information shall be provided for accepted reinsurance business. All insurance contracts shall be reported even if 
classified as investments contract on accounting basis. In case of products unbundled, the different parts of the product 
shall be reported in different rows, using different ID codes.  
All information shall be reported by product including the table on portfolio product. Reporting by fund number shall 
not mandatory, unless otherwise required by the national supervisory authority. Reporting of specific items related to 
the fund number can be defined by national supervisory authority.  
ITEM  INSTRUCTIONS  
Portfolio  
C0010  Product ID code  Internal product ID code used by the undertaking for the product. If a code is 
already in use or is attributed by the competent authority for supervisory 
purposes that code shall be used.EN  L 120/730 Official Journal of the European Union 5.5.2023